Investing in innovation to fortify the future of mental health care

SEC Filing

Form

Filing Date

Jun 25, 2025

Document Date

Jun 23, 2025

Form Description

Initial filing by director officer or owner of more than ten percent

Filing Group

3,4,5

Company

Vistagen Therapeutics, Inc

Issuer

VistaGen Therapeutics, Inc.

Filer

COTE ELISSA S.

View HTML

Annual Reports

Annual reports provide a comprehensive overview of the company for the past year

View Reports

Quarterly Reports

Quarterly reports provide a continuing view of the company's financial position

View Reports

SEC Filings

Statement of changes in beneficial ownership of securities

View Filings